0000054381-19-000008.txt : 20190225 0000054381-19-000008.hdr.sgml : 20190225 20190225161921 ACCESSION NUMBER: 0000054381-19-000008 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20190225 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KAMAN Corp CENTRAL INDEX KEY: 0000054381 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MACHINERY, EQUIPMENT & SUPPLIES [5080] IRS NUMBER: 060613548 STATE OF INCORPORATION: CT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35419 FILM NUMBER: 19629729 BUSINESS ADDRESS: STREET 1: 1332 BLUE HILLS AVE STREET 2: PO BOX 1 CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602436321 MAIL ADDRESS: STREET 1: 1332 BLUE HILLS AVE STREET 2: PO BOX 1 CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: KAMAN CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: KAMAN AIRCRAFT CORP DATE OF NAME CHANGE: 19680403 8-K 1 form8-kxq42018earningsrele.htm 8-K Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 25, 2019

Kaman Corporation
(Exact Name of Registrant as Specified in Its Charter)

Connecticut
(State or Other Jurisdiction of Incorporation)

001-35419
 
06-0613548
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
 
1332 Blue Hills Avenue, Bloomfield, Connecticut
 
06002
(Address of Principal Executive Offices)
 
(Zip Code)

(860) 243-7100
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    o






Item 2.02.    Results of Operations and Financial Condition

On February 25, 2019, the Company issued a press release summarizing the Company's financial results for the fiscal quarter and full year ended December 31, 2018. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

A conference call has been scheduled for tomorrow, February 26, 2019, at 8:30 AM ET. Listeners may access the call live by telephone at (844) 473-0975 and from outside the U.S. at (562) 350-0826 using the Conference ID: 7566935; or, via the Internet at www.kaman.com. A replay will also be available two hours after the call and can be accessed at (855) 859-2056 or (404) 537-3406 using the Conference ID: 7566935. In its discussion, management may reference certain non-GAAP financial measures related to company performance. A reconciliation of that information to the most directly comparable GAAP measures is provided in the press release, furnished herewith, a copy of which can be accessed in the investor relations section of the Company's website.

Item 9.01.    Financial Statements and Exhibits

(c)    Exhibits

The following document is furnished as an Exhibit pursuant to Item 2.02 hereof:

Exhibit 99.1 - Press Release of the Company, dated February 25, 2019, regarding financial performance for the fiscal quarter and full year ended December 31, 2018.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
KAMAN CORPORATION
 
 
 
 
By:
/s/ Shawn G. Lisle
 
 
Shawn G. Lisle
 
 
Senior Vice President and
 
 
General Counsel

Date: February 25, 2019





KAMAN CORPORATION AND SUBSIDIARIES

Index to Exhibits

Exhibit
Description
 
 
 
 
99.1
Attached



EX-99.1 2 exhibit991-q42018earningsr.htm EXHIBIT 99.1 Exhibit


Exhibit 99.1
image0a41.jpg
 
 
NEWS RELEASE
 
Kaman Corporation
 
1332 Blue Hills Avenue
Bloomfield, CT USA
 
P 860.243.7100
www.kaman.com

KAMAN REPORTS 2018 FOURTH QUARTER RESULTS
Fourth Quarter Highlights:
Diluted earnings per share of $0.84, or $1.22 adjusted*
Year-to-date operating cash flow of $162.4 million; Free Cash Flow* of $132.5 million
Consolidated backlog of $986.1 million, a 32.9% increase over 2017
Distribution sales up 6.5% to $280.1 million; Operating margin of 4.1%
Aerospace sales up 4.7% to $220.9 million; Operating margin of 18.9%, or 20.7% adjusted*

BLOOMFIELD, Conn. (February 25, 2019) - Kaman Corp. (NYSE:KAMN) today reported financial results for the fourth fiscal quarter ended December 31, 2018, as follows:
 
 
 
 
 
 
 
 
 
Table 1. Summary of Financial Results (unaudited)
 
 
 
 
 
 
In thousands except per share amounts
For the Three Months Ended
 
 
 
December 31,
2018
 
December 31,
2017
 
Change
 
 
Net sales:
 
 
 
 
 
 
 
Distribution
$
280,052

 
$
263,000

 
$
17,052

 
 
Aerospace
220,859

 
210,916

 
9,943

 
 
Net sales
$
500,911

 
$
473,916

 
$
26,995

 
 
 
 

 
 

 
 
 
 
Operating income:
 
 
 

 
 
 
 
Distribution
$
11,557

 
$
11,207

 
$
350

 
 
% of sales
4.1
%
 
4.3
%
 
(0.2
)%
 
 
Aerospace
41,748

 
44,594

 
(2,846
)
 
 
% of sales
18.9
%
 
21.1
%
 
(2.2
)%
 
 
Loss on sale of business
(5,722
)
 

 
(5,722
)
 
 
Net gain (loss) on sale of assets
(528
)
 
39

 
(567
)
 
 
Corporate expense
(12,846
)
 
(14,416
)
 
1,570

 
 
Operating income
$
34,209

 
$
41,424

 
$
(7,215
)
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA*:


 


 
 
 
 
Net earnings
$
23,577

 
$
13,797

 
$
9,780

 
 
Adjustments
36,340

 
40,155

 
(3,815
)
 
 
Adjusted EBITDA*
$
59,917

 
$
53,952

 
$
5,965

 
 
% of sales
12.0
%
 
11.4
%
 
0.6
 %
 
 
 
 
 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
 
 
Diluted earnings per share
$
0.84

 
$
0.49

 
$
0.35

 
 
Adjustments
0.38

 
0.37

 
0.01

 
 
Adjusted Diluted Earnings per Share*
$
1.22

 
$
0.86

 
$
0.36

 
 
 
 
 
 
 
 
 







Neal J. Keating, Chairman, President and Chief Executive Officer, commented, “We ended 2018 with strong top line growth at both segments, increasing sales for the quarter by 5.7% to over $500 million and achieving consolidated gross margins of 30.3%. Diluted earnings per share in the fourth quarter of $0.84 exceeded expectations, in part due to the shipment of JPF DCS safe and arm devices in December. Our results included a number of one-time charges in the quarter. When adjusted for these items, our adjusted diluted earnings per share was $1.22, a 41.9% increase over the adjusted results in the fourth quarter of 2017.

At Distribution, we continued to see strong organic sales growth, with sales per sales day* in the quarter up 6.5% over the prior year. This was the highest fourth quarter daily sales rate since 2014 and helped drive our full year sales per sales day* growth of 5.0%. Operating margin was 4.1% for the quarter and we ended 2018 with full year operating margins of 4.5%, or 4.6% adjusted*. A number of items impacted our full year operating profit performance when compared to 2017, including higher group health costs, costs associated with our one-time employee tax incentive and higher freight costs, which in total had an impact of approximately 30 bps.

At Aerospace, sales increased 4.7% when compared to the fourth quarter of 2017. Sales for specialty bearings products were strong in the quarter, with performance benefiting from the work performed to overcome the supplier issues that impacted results in the third quarter. Prior to year-end we received government export approval for our $48 million JPF DCS contract, and shipped a portion of this order in December, with delivery of the balance of the order expected in the first quarter of 2019. Also, during the quarter we secured three new K-MAX® contracts and successfully delivered three aircraft in the period with a total of five for the year. Operating margin of 18.9%, or 20.7% adjusted*, for the quarter benefited from the sales mix, offset by a number of costs, including costs associated with restructuring actions. These restructuring actions will help strengthen the performance at Aerospace through improved capacity utilization and operational efficiency.

We enter 2019 with positive momentum at both segments. Results at Distribution will benefit from the full year impact of recent corporate account wins and savings from the cost reduction actions taken in 2018. Aerospace enters 2019 with significant backlog and increased order rates across several of our products and programs and, when coupled with the actions we have taken to improve operating profit performance, is well positioned to benefit from its diverse mix of commercial and defense programs. And our cash flow performance for 2019 is expected to continue the recent trend of strong cash flow generation and we remain active in our corporate development activities.”

Chief Financial Officer, Robert D. Starr, commented, "In the fourth quarter we generated operating cash flows of $35.0 million, or Free Cash Flows* of $28.7 million, and ended the year with cash flows from operations of $162.4 million and Free Cash Flows* of $132.5 million. Although the full year result was slightly below expectations, 2018 Free Cash Flow* increased 154% over the Free Cash Flow* we generated in 2017. Our strong cash flow performance enabled us to make $30 million of discretionary contributions to our pension plan, up $20 million from the discretionary contributions we made in 2017, helping to improve the funded status of the plan.

In addition, we returned approximately $41 million in capital to shareholders during the year in the form of dividends and share repurchases, a 26% increase over 2017, while paying down over $100 million of debt. We enter 2019 with an extremely strong balance sheet and are well positioned to execute on our strategic goals.





 
Moving to our outlook for 2019, we expect overall improved results for the year due to an increase in operating margin at both segments, and strong top line growth at Distribution. The approximately 11% increase in the mid-point of expected segment operating income for 2019 is expected to be largely offset by a below the line reduction in non-cash pension and post-retirement benefit income.

At Distribution, we expect sales in the range of $1.19 billion to $1.22 billion, an implied growth rate of 6.0% at the midpoint of the range. Top line performance will benefit from our corporate account wins reaching their full-year run rate in 2019, as well as a number of other sales initiatives designed to increase market share. We expect operating margins for the segment in the range of 5.0% to 5.3%.

At Aerospace, we expect sales in the range of $720.0 million to $750.0 million, with operating margins of 16.5% to 17.0%. Aerospace sales performance at the mid-point will be relatively flat with the prior year, despite an approximately $45.0 million reduction in sales resulting from lower revenue on helicopter and metallic structures programs combined with the absence of sales from Engineering Services and Tooling businesses. Sales from the remaining Aerospace business is expected to increase approximately 6.0%, highlighted by increased sales for our specialty bearings and engineered products and JPF safe and arm devices. The expected increase in operating margin will be driven by expected sales mix in 2019 and the benefit from the sale of the Engineering Services and Tooling businesses.

We expect another strong year of cash flow generation in 2019, with cash flows from operations expected to be in the range of $105.0 million to $125.0 million, resulting in a Free Cash Flow* expectation in the range of $70.0 million to $90.0 million.

Moving to the cadence of earnings for the year, we expect less than 10% of earnings in the first quarter and approximately 40% in the fourth quarter. Similar to 2018, earnings for 2019 are expected to be largely driven by the timing of sales and profit for our specialty bearings products and JPF safe and arm devices."

2019 Outlook
The Company's 2019 outlook is as follows:
Distribution:
Sales of $1.19 billion to $1.22 billion
Operating margins of 5.0% to 5.3%
Depreciation and amortization expense of approximately $16.0 million
Aerospace:
Sales of $720.0 million to $750.0 million
Operating margins of 16.5% to 17.0%
Depreciation and amortization expense of approximately $21.0 million
Interest expense of approximately $20.0 million
Corporate expenses of approximately $58.0 million to $59.0 million
Net periodic pension benefit of approximately $1.5 million
Estimated annualized tax rate of approximately 24.0%
Consolidated depreciation and amortization expense of approximately $41 million
Capital expenditures of approximately $35.0 million
Cash flows from operations in the range of $105.0 million to $125.0 million; Free Cash Flow* in the range of $70.0 million to $90.0 million
Weighted average diluted shares outstanding of 28.1 million






Please see the MD&A section of the Company's Form 10-K filed with the Securities and Exchange Commission concurrently with the issuance of this release for greater detail on our results and various company programs.

A conference call has been scheduled for tomorrow, February 26, 2019, at 8:30 AM ET. Listeners may access the call live by telephone at (844) 473-0975 and from outside the U.S. at (562) 350-0826 using the Conference ID: 7566935; or, via the Internet at www.kaman.com. A replay will also be available two hours after the call and can be accessed at (855) 859-2056 or (404) 537-3406 using the Conference ID: 7566935. In its discussion, management may reference certain non-GAAP financial measures related to company performance. A reconciliation of that information to the most directly comparable GAAP measures is provided in this release.

About Kaman Corporation
Kaman Corporation, founded in 1945 by aviation pioneer Charles H. Kaman, and headquartered in Bloomfield, Connecticut conducts business in the aerospace and industrial distribution markets.  The company produces and markets proprietary aircraft bearings and components; super precision, miniature ball bearings; complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft; safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of  our SH-2G Super Seasprite maritime helicopters; manufacture and support of our K-MAX® manned and unmanned medium-to-heavy lift helicopters.  The company is a leading distributor of industrial parts, and operates approximately 220 service facilities, including distribution centers, assembly, fabrication and repair facilities across the U.S. and Puerto Rico. Kaman offers more than six million items including electro-mechanical products, bearings, power transmission, motion control and electrical and fluid power components, automation and MRO supplies to customers in virtually every industry.  Additionally, Kaman provides engineering, design and support for automation, electrical, linear, hydraulic and pneumatic systems as well as belting and rubber fabrication, customized mechanical services, hose assemblies, repair, fluid analysis and motor management. More information is available at www.kaman.com.

Table 2. Summary of Segment Information (in thousands) (unaudited)
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
December 31,
2018

December 31,
2017
 
December 31,
2018
 
December 31,
2017
Net sales:
 
 
 
 
 
 
 
   Distribution
$
280,052


$
263,000

 
$
1,139,431

 
$
1,080,965

   Aerospace
220,859


210,916

 
735,994

 
724,944

     Net sales
$
500,911

 
$
473,916

 
$
1,875,425

 
$
1,805,909

 
 

 
 

 
 
 
 
Operating income:
 

 
 

 
 
 
 
   Distribution
$
11,557


$
11,207

 
$
51,529

 
$
51,372

   Aerospace
41,748


44,594

 
94,357

 
117,654

   Loss on sale of business
(5,722
)


 
(5,722
)
 

   Net gain (loss) on sale of assets
(528
)

39

 
1,700

 
256

   Corporate expense
(12,846
)

(14,416
)
 
(58,800
)
 
(58,163
)
     Operating income
$
34,209

 
$
41,424

 
$
83,064

 
$
111,119

 
 
 
 
 
 
 
 





Table 3. Depreciation and Amortization by Segment (in thousands) (unaudited)
 
 
 
 
 
 
 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
December 31,
2018

December 31,
2017

December 31,
2018

December 31,
2017
Depreciation and Amortization:
 
 
 
 
 
 
 
   Distribution
$
3,734

 
$
3,548

 
$
14,154

 
$
15,083

   Aerospace
5,945

 
6,128

 
24,506

 
23,717

   Corporate
850

 
876

 
3,369

 
3,671

Consolidated Total
$
10,529


$
10,552


$
42,029


$
42,471


Non-GAAP Measures Disclosure

Management believes that the Non-GAAP (i.e. Financial measures that are noted computed in accordance with Generally Accepted Accounting Principles) financial measures identified by an asterisk (*) used in this release or in other disclosures provide important perspectives into the Company's ongoing business performance. The Company does not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. We define the Non-GAAP measures used in this release and other disclosures as follows:

Organic Sales - Organic Sales is defined as "Net Sales" less sales derived from acquisitions completed during the preceding twelve months. We believe that this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, which can obscure underlying trends. We also believe that presenting Organic Sales separately for our segments provides management and investors with useful information about the trends impacting our segments and enables a more direct comparison to other businesses and companies in similar industries. Management recognizes that the term "Organic Sales" may be interpreted differently by other companies and under different circumstances. No other adjustments were made during the three-month and twelve-month fiscal periods ended December 31, 2018 and December 31, 2017. The following table illustrates the calculation of Organic Sales using the GAAP measure, "Net Sales".
Table 4. Organic Sales (in thousands) (unaudited)
 
 
 
 
 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
December 31,
2018

December 31,
2017

December 31,
2018

December 31,
2017
Distribution
 
 
 
 
 
 
 
Net sales
$
280,052

 
$
263,000

 
$
1,139,431

 
$
1,080,965

Acquisition Sales

 

 

 

Organic Sales
$
280,052

 
$
263,000

 
$
1,139,431

 
$
1,080,965

Aerospace
 
 
 
 
 
 
 
Net sales
$
220,859

 
$
210,916

 
$
735,994

 
$
724,944

Acquisition Sales

 

 

 

Organic Sales
$
220,859

 
$
210,916

 
$
735,994

 
$
724,944

Consolidated
 
 
 
 
 
 
 
Net sales
$
500,911

 
$
473,916

 
$
1,875,425

 
$
1,805,909

Acquisition Sales

 

 

 

Organic Sales
$
500,911

 
$
473,916

 
$
1,875,425

 
$
1,805,909







Organic Sales per Sales Day - Organic Sales per Sales Day is defined as GAAP "Net sales of the Distribution segment" less sales derived from acquisitions completed during the preceding twelve months divided by the number of Sales Days in a given period. Sales days ("Sales Days") are the days that the Distribution segment's branch locations were open for business and exclude weekends and holidays. Management believes Organic Sales per Sales Day provides an important perspective on how net sales may be impacted by the number of days the segment is open for business and provides a basis for comparing periods in which the number of Sales Days differs.  

The following table illustrates the calculation of Organic Sales per Sales Day using “Net sales: Distribution” from the “Segment and Geographic Information” footnote in the “Notes to Consolidated Financial Statements” included in the Company's Form 10-K filed with the Securities and Exchange Commission on February 25, 2019.

Table 5. Distribution - Organic Sales Per Sales Day (in thousands, except days) (unaudited)
 
For the Three Months Ended

For the Twelve Months Ended
 
 
December 31,
2018

December 31,
2017

December 31,
2018

December 31,
2017
 
 
(in thousands)
Current period
 
 
 
 
 
 
 
 
Net sales
 
$
280,052

 
$
263,000

 
$
1,139,431

 
$
1,080,965

Sales days
 
62

 
62

 
253

 
252

Sales per Sales Day for the current period
a
$
4,517

 
$
4,242

 
$
4,504

 
$
4,290

 
 
 
 
 
 
 
 
 
Prior period
 
 
 
 
 
 
 
 
Net sales from the prior year
 
$
263,000

 
$
257,218

 
$
1,080,965

 
$
1,106,322

Sales days from the prior year
 
62

 
61

 
252

 
253

Sales per Sales day from the prior year
b
$
4,242

 
$
4,217

 
$
4,290

 
$
4,373

 
 
 
 
 
 
 
 
 
% change
(a-b)÷b
6.5
%
 
0.6
%
 
5.0
%
 
(1.9
)%

Table 6. Distribution - Sales Days
 
 
 
 
 
 
 
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
Distribution Sales Days
 
 
 
 
 
 
 
2019 Sales Days by quarter
63

 
64

 
63

 
63

2018 Sales Days by quarter
64

 
64

 
63

 
62

2017 Sales Days by quarter
64

 
64

 
62

 
62


Adjusted EBITDA - Adjusted EBITDA is defined as net earnings before interest, taxes, other expense (income), net, depreciation and amortization and certain items that are not indicative of the operating performance of the Company's segments or corporate function for the period presented. Adjusted EBITDA differs from net earnings, as calculated in accordance with GAAP, in that it excludes interest expense, net, income tax expense, depreciation and amortization, other expense (income), net and certain items that are not indicative of the operating performance of the Company's segments or corporate function for the period presented. We have made numerous investments in our business, such as acquisitions and capital expenditures, including facility improvements, new machinery and equipment, improvements to our information technology infrastructure and new ERP systems, which we have adjusted for in Adjusted EBITDA. Adjusted EBITDA also does not give effect to cash used for debt service requirements and thus does not reflect funds available for distributions, reinvestments or other discretionary uses.





Management believes Adjusted EBITDA provides an additional perspective on the operating results of the organization and its earnings capacity and helps improve the comparability of our results between periods because it provides a view of our operations that excludes items that management believes are not reflective of operating performance, such as items traditionally removed from net earnings in the calculation of EBITDA as well as Other expense (income), net and certain items that are not indicative of the operating performance of the Company's segments or corporate function for the period presented. Adjusted EBITDA is not presented as an alternative measure of operating performance, as determined in accordance with GAAP. No other adjustments were made during the three-month and twelve-month fiscal periods ended December 31, 2018 and December 31, 2017. The following table illustrates the calculation of Adjusted EBITDA using GAAP measures:

Table 7. Adjusted EBITDA (in thousands) (unaudited)
 
 
 
 
 
 
For the Three Months Ended

For the Twelve Months Ended
 
December 31,
2018

December 31,
2017

December 31,
2018

December 31,
2017
Adjusted EBITDA
 
 
 
 
 
 
 
Consolidated Results
 
 
 
 
 
 
 
Sales
$
500,911

 
$
473,916

 
$
1,875,425

 
$
1,805,909

 
 
 
 
 
 
 
 
Net earnings
$
23,577

 
$
13,797

 
$
54,169

 
$
49,826

 
 
 
 
 
 
 
 
Interest expense, net
$
4,658

 
$
5,035

 
$
20,097

 
$
20,581

Income tax expense
9,041

 
23,518

 
21,068

 
44,552

Other expense (income), net
17

 
(73
)
 
(143
)
 
(784
)
Depreciation and amortization
10,529

 
10,552

 
42,029

 
42,471

Other Adjustments:
 
 
 
 
 
 
 
Restructuring and severance costs
2,704

 
355

 
8,008

 
2,855

Non-cash intangible asset impairment charge

 

 
10,039

 

Non-cash write-off of inventory

 

 
709

 

Employee tax-related matters in foreign operations
1,761




3,040



Cost associated with corporate development activities
1,247




3,409



Cost associated with senior executive retirement


768




2,882

Loss on sale of U.K. Tooling business
5,722

 

 
5,722

 

Loss on sale of assets and liabilities of Engineering Services business
661




661



Gain on the sale of land

 

 
(1,520
)
 

Adjustments
$
36,340

 
$
40,155

 
$
113,119

 
$
112,557

 
 
 
 
 
 
 
 
Adjusted EBITDA
$
59,917

 
$
53,952

 
$
167,288

 
$
162,383

   Adjusted EBITDA margin
12.0
%
 
11.4
%
 
8.9
%
 
9.0
%






Free Cash Flow - Free Cash Flow is defined as GAAP “Net cash provided by (used in) operating activities” in a period less “Expenditures for property, plant & equipment” in the same period. Management believes Free Cash Flow provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions, as it may exclude certain mandatory expenditures such as repayment of maturing debt and other contractual obligations. Management uses Free Cash Flow internally to assess overall liquidity. The following table illustrates the calculation of Free Cash Flow using “Net cash provided by (used in) operating activities” and “Expenditures for property, plant & equipment”, GAAP measures from the Condensed Consolidated Statements of Cash Flows included in this release.
Table 8. Free Cash Flow (in thousands) (unaudited)
 
 
 
 
 
 
 
 
For the Twelve Months Ended
 
For the Nine Months Ended
 
For the Three Months Ended
 
 
December 31,
2018
 
September 28,
2018
 
December 31,
2018
Net cash provided by operating activities
 
$
162,368

 
$
127,398

 
$
34,970

Expenditures for property, plant & equipment
 
(29,871
)
 
(23,630
)
 
(6,241
)
Free Cash Flow
 
$
132,497

 
$
103,768

 
$
28,729


Table 9. Free Cash Flow - 2019 Outlook (in millions)
2019 Outlook
Free Cash Flow:
 
 
 
     Net cash provided by operating activities
$
105.0

to
$
125.0

     Less: Expenditures for property, plant and equipment
(35.0
)
to
(35.0
)
          Free Cash Flow
$
70.0

to
$
90.0


Debt to Capitalization Ratio - Debt to Capitalization Ratio is calculated by dividing debt by capitalization. Debt is defined as GAAP “Current portion of long-term debt” plus “Long-term debt, excluding current portion”. Capitalization is defined as Debt plus GAAP “Total shareholders' equity”. Management believes that Debt to Capitalization Ratio is a measurement of financial leverage and provides an insight into the financial structure of the Company and its financial strength. The following table illustrates the calculation of Debt to Capitalization Ratio using GAAP measures from the Condensed Consolidated Balance Sheets included in this release.
Table 10. Debt to Capitalization Ratio (in thousands) (unaudited)
 
 
 
 
 
 
December 31,
2018
 
December 31,
2017
Current portion of long-term debt
 
$
9,375

 
$
7,500

Long-term debt, excluding current portion, net of debt issuance costs
 
284,256

 
391,651

Debt
 
$
293,631

 
$
399,151

Total shareholders' equity
 
633,157

 
635,656

Capitalization
 
$
926,788

 
$
1,034,807

Debt to Capitalization Ratio
 
31.7
%
 
38.6
%

Adjusted Net Earnings and Adjusted Diluted Earnings Per Share - Adjusted Net Earnings and Adjusted Diluted Earnings per Share are defined as GAAP "Net earnings" and "Diluted earnings per share", less items that are not indicative of the operating performance of the business for the periods presented. These items are included in the reconciliation below. Management uses Adjusted Net Earnings and Adjusted Diluted Earnings per Share to evaluate performance period over period, to analyze the underlying trends in our business and to assess its performance relative to its competitors. We believe that this information is useful for investors and financial institutions seeking to analyze and compare companies on the basis of operating performance.






The following table illustrates the calculation of Adjusted Net Earnings and Adjusted Diluted Earnings per Share using “Net earnings” and “Diluted earnings per share” from the “Consolidated Statements of Operations” included in the Company's Form 10-K filed with the Securities and Exchange Commission on February 25, 2019.

Table 11. Adjusted Net Earnings and Adjusted Diluted Earnings per Share
 
 
 
 
(In thousands except per share amounts) (unaudited)
 
 
 
 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
December 31,
2018
 
December 31,
2017
 
December 31,
2018
 
December 31,
2017
Adjustments to Net Earnings, pre tax
 
 
 
 
 
 
 
Restructuring and severance costs at Aerospace
$
2,305

 
$
161

 
$
7,016

 
$
2,661

Restructuring and severance costs at Distribution
62

 
194

 
655

 
194

Restructuring and severance costs at Corporate
337

 

 
337

 

Non-cash non-tax write-off of inventory

 

 
709

 

Employee tax-related matters in foreign operations
1,761

 

 
3,040

 

Cost associated with corporate development activities
1,247

 

 
3,409

 

Senior executive separation costs

 
768

 

 
2,882

Loss on sale of assets and liabilities of Engineering Services business
661

 

 
661

 

Gain on the sale of land




(1,520
)


Non-cash non-tax intangible asset impairment charge

 

 
10,039

 

Loss on sale of U.K. Tooling business
5,722

 

 
5,722

 

Tax expense associated with the revaluation of U.S. deferred tax assets due to tax reform

 
9,733

 

 
9,733

Adjustments, pre tax
$
12,095

 
$
10,856

 
$
30,068

 
$
15,470

 
 
 
 
 
 
 
 
Tax Effect of Adjustments to Net Earnings
 
 
 
 
 
 
 
Restructuring and severance costs at Aerospace
$
576

 
$
56

 
$
1,754

 
$
931

Restructuring and severance costs at Distribution
16

 
68

 
164

 
68

Restructuring and severance costs at Corporate
84

 

 
84

 

Non-cash non-tax write-off of inventory

 

 

 

Employee tax-related matters in foreign operations
115

 

 
435

 

Cost associated with corporate development activities
312

 

 
852

 

Senior executive separation costs

 
269

 

 
1,009

Loss on sale of assets and liabilities of Engineering Services business
165

 

 
165

 

Gain on the sale of land

 

 
(380
)
 

Non-cash non-tax intangible asset impairment charge

 

 

 

Loss on sale of U.K. Tooling business

 

 

 

Tax expense associated with the revaluation of U.S. deferred tax assets due to tax reform

 

 

 

Tax effect of Adjustments
$
1,268

 
$
393

 
$
3,074

 
$
2,008

 
 
 
 
 
 
 
 





Table 11. Adjusted Net Earnings and Adjusted Diluted Earnings per Share
 
 
 
 
(In thousands except per share amounts) (unaudited)
 
 
 
 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
December 31,
2018
 
December 31,
2017
 
December 31,
2018
 
December 31,
2017
Adjustments to Net Earnings, net of tax
 
 
 
 
 
 
 
GAAP Net Earnings, as reported
$
23,577

 
$
13,797

 
$
54,169

 
$
49,826

Restructuring and severance costs at Aerospace
1,729

 
105

 
5,262

 
1,730

Restructuring and severance costs at Distribution
46

 
126

 
491

 
126

Restructuring and severance costs at Corporate
253

 

 
253

 

Non-cash non-tax write-off of inventory

 

 
709

 

Employee tax-related matters in foreign operations
1,646

 

 
2,605

 

Cost associated with corporate development activities
935

 

 
2,557

 

Senior executive separation costs

 
499

 

 
1,873

Loss on sale of assets and liabilities of Engineering Services business
496

 

 
496

 

Gain on the sale of land

 

 
(1,140
)
 

Non-cash non-tax intangible asset impairment charge

 

 
10,039

 

Loss on sale of U.K. Tooling business
5,722

 

 
5,722

 

Tax expense associated with the revaluation of U.S. deferred tax assets due to tax reform

 
9,733

 

 
9,733

Adjusted Net Earnings
$
34,404

 
$
24,260

 
$
81,163

 
$
63,288

 
 
 
 
 
 
 
 
Calculation of Adjusted Diluted Earnings per Share
 
 
 
 
 
 
 
GAAP diluted earnings per share
$
0.84

 
$
0.49

 
$
1.92

 
$
1.75

Restructuring and severance costs at Aerospace
0.06

 

 
0.19

 
0.06

Restructuring and severance costs at Distribution

 

 
0.01

 

Restructuring and severance costs at Corporate
0.01

 

 
0.01

 

Non-cash non-tax write-off of inventory

 

 
0.03

 

Employee tax-related matters in foreign operations
0.06

 

 
0.09

 

Cost associated with corporate development activities
0.03

 

 
0.09

 

Senior executive separation costs

 
0.02

 

 
0.07

Loss on sale of assets and liabilities of Engineering Services business
0.02

 

 
0.02

 

Gain on the sale of land

 

 
(0.04
)
 

Non-cash non-tax intangible asset impairment charge

 

 
0.36

 

Loss on sale of U.K. Tooling business
0.20

 

 
0.20

 

Tax expense associated with the revaluation of U.S. deferred tax assets due to tax reform

 
0.35

 

 
0.35

Adjusted Diluted Earnings per Share
$
1.22


$
0.86

 
$
2.88

 
$
2.23

 
 
 
 
 
 
 
 
Diluted weighted average shares outstanding
28,119

 
28,172

 
28,223

 
28,418







Adjusted Net Sales and Adjusted Operating Income - Adjusted Net Sales is defined as net sales, less items not indicative of normal sales, such as revenue recorded related to the settlement of claims. Adjusted Operating Income is defined as operating income, less items that are not indicative of the operating performance of the Company's segments or corporate function for the period presented. These items are included in the reconciliation below. Management uses Adjusted Net Sales and Adjusted Operating Income to evaluate performance period over period, to analyze underlying trends in our segments and corporate function and to assess their performance relative to their competitors. We believe that this information is useful for investors and financial institutions seeking to analyze and compare companies on the basis of operating performance. The following table illustrates the calculation of Adjusted Operating Income using information found in Note 20, Segment and Geographic Information, to the Consolidated Financial Statements included in the Company's Form 10-K filed with the Securities and Exchange Commission on February 25, 2019.





Table 12. Adjusted Net Sales and Adjusted Operating Income
 
 
 
 
(In thousands) (unaudited)
 
 
 
 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
December 31,
2018
 
December 31,
2017
 
December 31,
2018
 
December 31,
2017
DISTRIBUTION SEGMENT OPERATING INCOME:
 
 
 
 
 
 
 
Net Sales
$
280,052

 
$
263,000

 
$
1,139,431

 
$
1,080,965

GAAP Operating income - Distribution segment
11,557

 
11,207

 
51,529

 
51,372

% of GAAP net sales
4.1
%
 
4.3
%
 
4.5
%
 
4.8
%
Restructuring and severance costs
62

 
194

 
655

 
194

Adjusted Operating Income - Distribution segment
$
11,619

 
$
11,401

 
$
52,184

 
$
51,566

% of net sales
4.1
%
 
4.3
%
 
4.6
%
 
4.8
%
AEROSPACE SEGMENT OPERATING INCOME:
 
 
 
 
 
 
 
Net Sales
$
220,859

 
$
210,916

 
$
735,994

 
$
724,944

GAAP Operating income - Aerospace segment
41,748

 
44,594

 
94,357

 
117,654

% of GAAP net sales
18.9
%
 
21.1
%
 
12.8
%
 
16.2
%
Restructuring and severance costs
2,305

 
161

 
7,016

 
2,661

Non-cash intangible asset impairment charge

 

 
10,039

 

Non-cash write-off of inventory

 

 
709

 

Employee tax-related matters in foreign operations
1,761

 

 
3,040

 

Adjusted Operating Income - Aerospace segment
$
45,814

 
$
44,755

 
$
115,161

 
$
120,315

% of GAAP net sales
20.7
%
 
21.2
%
 
15.6
%
 
16.6
%
CORPORATE EXPENSE:
 
 
 
 
 
 
 
GAAP Corporate Expense
$
(12,846
)
 
$
(14,416
)
 
$
(58,800
)
 
$
(58,163
)
Cost associated with corporate development activities
1,247

 

 
3,409

 

Restructuring and severance costs
337

 

 
337

 

Senior executive separation costs

 
768

 

 
2,882

Adjusted Corporate Expense
$
(11,262
)
 
$
(13,648
)
 
$
(55,054
)
 
$
(55,281
)
CONSOLIDATED OPERATING INCOME:
 
 
 
 
 
 
 
Net Sales
$
500,911

 
$
473,916

 
$
1,875,425

 
$
1,805,909

GAAP - Operating income
34,209

 
41,424

 
83,064

 
111,119

% of GAAP net sales
6.8
%
 
8.7
%
 
4.4
%
 
6.2
%
Restructuring and severance costs at Distribution
62

 
194

 
655

 
194

Restructuring and severance costs at Aerospace
2,305

 
161

 
7,016

 
2,661

Restructuring and severance costs at Corporate
337

 

 
337

 

Non-cash non-tax intangible asset impairment charge

 

 
10,039

 

Non-cash non-tax write-off of inventory

 

 
709

 

Employee tax-related matters in foreign operations
1,761

 

 
3,040

 

Cost associated with corporate development activities
1,247

 

 
3,409

 

Senior executive separation costs

 
768

 

 
2,882

Loss on the sale of assets and liabilities of Engineering Services business
661

 

 
661

 

Loss on the sale of U.K. Tooling business
5,722

 

 
5,722

 

Gain on the sale of land

 

 
(1,520
)
 

Adjusted Operating Income
$
46,304

 
$
42,547

 
$
113,132

 
$
116,856

% of GAAP net sales
9.2
%
 
9.0
%
 
6.0
%
 
6.5
%






FORWARD-LOOKING STATEMENTS

This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others: (i) changes in domestic and foreign economic and competitive conditions in markets served by the Company, particularly the defense, commercial aviation and industrial production markets; (ii) changes in government and customer priorities and requirements (including cost-cutting initiatives, government and customer shut-downs, the potential deferral of awards, terminations or reductions of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional actions or automatic sequestration); (iii) changes in geopolitical conditions in countries where the Company does or intends to do business; (iv) the successful conclusion of competitions for government programs (including new, follow-on and successor programs) and thereafter successful contract negotiations with government authorities (both foreign and domestic) for the terms and conditions of the programs; (v) the timely receipt of any necessary export approvals and/or other licenses or authorizations from the U.S. Government; (vi) timely satisfaction or fulfillment of material contractual conditions precedents in customer purchase orders, contracts, or similar arrangements; (vii) the existence of standard government contract provisions permitting renegotiation of terms and termination for the convenience of the government; (viii) the successful resolution of government inquiries or investigations relating to our businesses and programs; (ix) risks and uncertainties associated with the successful implementation and ramp up of significant new programs, including the ability to manufacture the products to the detailed specifications required and recover start-up costs and other investments in the programs; (x) potential difficulties associated with variable acceptance test results, given sensitive production materials and extreme test parameters; (xi) the receipt and successful execution of production orders under the Company's existing U.S. government JPF contract, including the exercise of all contract options and receipt of orders from allied militaries, but excluding any next generation programmable fuze programs, as all have been assumed in connection with goodwill impairment evaluations; (xii) the continued support of the existing K-MAX® helicopter fleet, including sale of existing K-MAX® spare parts inventory and the receipt of orders for new aircraft sufficient to recover our investments in the K-MAX® production line; (xiii) the accuracy of current cost estimates associated with environmental remediation activities; (xiv) the profitable integration of acquired businesses into the Company's operations; (xv) the ability to implement our ERP systems in a cost-effective and efficient manner, limiting disruption to our business, and allowing us to capture their planned benefits while maintaining an adequate internal control environment; (xvi) the ability to recover from cyber-based or other security attacks, information technology failures or other disruptions; (xvii) changes in supplier sales or vendor incentive policies; (xviii) the ability of our suppliers to satisfy their performance obligations; (xix) the effects of price increases or decreases; (xx) the effects of pension regulations, pension plan assumptions, pension plan asset performance, future contributions and the pension freeze, including the ultimate determination of the U.S. Government's share of any pension curtailment adjustment calculated in accordance with CAS 413; (xxi) future levels of indebtedness and capital expenditures; (xxii) the continued availability of raw materials and other commodities in adequate supplies and the effect of increased costs for such items; (xxiii) the effects of currency exchange rates and foreign competition on future operations; (xxiv) changes in laws and regulations, taxes, interest rates, inflation rates and general business conditions; (xxv) the effects, if any, of the UK's exit from the EU; (xxvi) future repurchases and/or issuances of common stock; (xxvii) the occurrence of unanticipated restructuring costs or the failure to realize anticipated savings or benefits from past or future expense reduction actions; (xxviii) the ability to recruit and retain skilled employees; and (xxix) other risks and uncertainties set forth herein and in our 2018 Form 10-K February 25, 2019.

Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact: James Coogan
V.P., Investor Relations
(860) 243-6342
James.Coogan@kaman.com





KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(In thousands, except per share amounts) (unaudited)

 
 
For the Three Months Ended
 
For the Twelve Months Ended
 
 
December 31,
2018

December 31,
2017
 
December 31,
2018
 
December 31,
2017
Net sales
 
$
500,911


$
473,916


$
1,875,425


$
1,805,909

Cost of sales
 
349,182

 
325,629

 
1,325,388

 
1,260,318

Gross profit
 
151,729

 
148,287

 
550,037

 
545,591

Selling, general and administrative expenses
 
108,566

 
106,741

 
444,904

 
432,067

Other intangible assets impairment
 

 

 
10,039

 

Restructuring costs
 
2,704

 
161

 
8,008


2,661

Loss on sale of business
 
5,722

 

 
5,722

 

Net (gain) loss on sale of assets
 
528

 
(39
)
 
(1,700
)
 
(256
)
Operating income
 
34,209

 
41,424

 
83,064

 
111,119

Interest expense, net
 
4,658


5,035


20,097


20,581

Non-service pension and post retirement benefit cost (income)
 
(3,084
)
 
(853
)
 
(12,127
)
 
(3,056
)
Other (income) expense, net
 
17


(73
)

(143
)

(784
)
Earnings before income taxes
 
32,618

 
37,315

 
75,237

 
94,378

Income tax expense
 
9,041


23,518


21,068


44,552

Net earnings
 
$
23,577


$
13,797


$
54,169


$
49,826

 
 
 
 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
 

 
 

Basic earnings per share
 
$
0.84

 
$
0.50

 
$
1.94

 
$
1.80

Diluted earnings per share
 
$
0.84


$
0.49


$
1.92


$
1.75

Weighted average shares outstanding:
 
 
 
 
 
 

 
 

Basic
 
27,951

 
27,837

 
27,945

 
27,611

Diluted
 
28,119


28,172


28,223


28,418








KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts) (unaudited)
 
 
December 31,
2018

December 31,
2017
Assets
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
27,711

 
$
36,904

Accounts receivable, net
 
301,094

 
313,451

Contract assets
 
108,861

 

Contract costs, current portion
 
5,993

 

Inventories
 
294,912

 
367,437

Income tax refunds receivable
 
1,752

 
2,889

Other current assets
 
32,782

 
27,188

Total current assets
 
773,105

 
747,869

Property, plant and equipment, net of accumulated depreciation of $262,306 and $252,611, respectively
 
184,224

 
185,452

Goodwill
 
345,365

 
351,717

Other intangible assets, net
 
91,007

 
117,118

Deferred income taxes
 
24,437

 
27,603

Contract costs, noncurrent portion
 
10,666

 

Other assets
 
31,509

 
25,693

Total assets
 
$
1,460,313

 
$
1,455,452

Liabilities and Shareholders’ Equity
 
 

 
 

Current liabilities:
 
 

 
 

Current portion of long-term debt, net of debt issuance costs
 
$
9,375

 
$
7,500

Accounts payable – trade
 
158,627

 
127,591

Accrued salaries and wages
 
46,634

 
48,352

Contract liabilities, current portion
 
28,865

 

Advances on contracts
 

 
8,527

Income taxes payable
 
139

 
1,517

Other current liabilities
 
54,836

 
52,812

Total current liabilities
 
298,476

 
246,299

Long-term debt, excluding current portion, net of debt issuance costs
 
284,256

 
391,651

Deferred income taxes
 
7,027

 
8,024

Underfunded pension
 
104,988

 
126,924

Contract liabilities, noncurrent portion
 
78,562

 

Other long-term liabilities
 
53,847

 
46,898

Commitments and contingencies
 
 
 
 
Shareholdersequity:
 
 

 
 

Preferred stock, $1 par value, 200,000 shares authorized; none outstanding
 

 

Common stock, $1 par value, 50,000,000 shares authorized; voting; 29,544,714 and 29,141,467 shares issued, respectively
 
29,545

 
29,141

Additional paid-in capital
 
200,474

 
185,332

Retained earnings
 
610,103

 
587,877

Accumulated other comprehensive income (loss)
 
(134,898
)
 
(115,814
)
Less 1,672,917 and 1,325,975 shares of common stock, respectively, held in treasury, at cost
 
(72,067
)
 
(50,880
)
Total shareholders’ equity
 
633,157

 
635,656

Total liabilities and shareholders’ equity
 
$
1,460,313

 
$
1,455,452










KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands) (unaudited)

 
 
For the Twelve Months Ended
 
 
December 31,
2018
 
December 31,
2017
Cash flows from operating activities:
 
 

 
 

Net earnings
 
$
54,169

 
$
49,826

Adjustments to reconcile net earnings to net cash provided by operating activities:
 
 

 
 

Depreciation and amortization
 
42,029

 
42,471

Amortization of debt issuance costs
 
1,806

 
2,014

Accretion of convertible notes discount
 
2,596

 
3,410

Provision for doubtful accounts
 
1,123

 
1,094

Loss on sale of business
 
5,722

 

Net gain on sale of assets
 
(1,700
)
 
(256
)
Other intangible assets impairment
 
10,039

 

Loss on debt extinguishment
 

 
137

Net loss (gain) on derivative instruments
 
829

 
(1,126
)
Stock compensation expense
 
6,505

 
5,956

Deferred income taxes
 
10,417

 
24,555

Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
 

 
 

Accounts receivable
 
(19,398
)
 
(77,560
)
Contract assets
 
(27,595
)
 

Contract costs
 
(5,834
)
 

Inventories
 
(4,599
)
 
31,095

Income tax refunds receivable
 
1,136

 
3,180

Other assets
 
(7,316
)
 
1,747

Accounts payable - trade
 
30,177

 
10,164

Contract liabilities
 
96,034

 

Accrued contract losses
 
(5
)
 
(957
)
Accrued restructuring costs
 
(355
)
 
1,122

Advances on contracts
 

 
(4,829
)
Other current liabilities
 
1,942

 
(366
)
Income taxes payable
 
(2,915
)
 
212

Pension liabilities
 
(38,179
)
 
(11,318
)
Other long-term liabilities
 
5,740

 
(686
)
Net cash provided by operating activities
 
162,368

 
79,885






KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands) (unaudited)

 
 
For the Twelve Months Ended
 
 
December 31,
2018
 
December 31,
2017
Cash flows from investing activities:
 
 

 
 

Proceeds from sale of assets
 
2,905

 
618

Expenditures for property, plant & equipment
 
(29,871
)
 
(27,631
)
Acquisition of businesses including earn out adjustments, net of cash acquired
 

 
(1,365
)
Other, net
 
(2,995
)
 
(3,457
)
Cash used in investing activities
 
(29,961
)
 
(31,835
)
Cash flows from financing activities:
 
 

 
 

Net repayments under revolving credit agreements
 
(98,087
)
 
(75,988
)
Debt repayment
 
(7,500
)
 
(6,875
)
Proceeds from issuance of 2024 convertible notes
 

 
200,000

Repayment of 2017 convertible notes
 

 
(175,151
)
Purchase of capped call - 2024 convertible notes
 

 
(20,500
)
Proceeds from bond hedge settlement - 2017 convertible notes
 

 
58,564

Net change in bank overdraft
 
(422
)
 
(1,146
)
Proceeds from exercise of employee stock awards
 
7,351

 
7,370

Purchase of treasury shares
 
(19,278
)
 
(11,552
)
Dividends paid
 
(22,349
)
 
(21,462
)
Debt and equity issuance costs
 

 
(7,473
)
Other
 
(1,077
)
 
(523
)
Net cash used in financing activities
 
(141,362
)
 
(54,736
)
Net decrease in cash and cash equivalents
 
(8,955
)
 
(6,686
)
Effect of exchange rate changes on cash and cash equivalents
 
(238
)
 
2,385

Cash and cash equivalents at beginning of period
 
36,904

 
41,205

Cash and cash equivalents at end of period
 
$
27,711

 
$
36,904




GRAPHIC 3 image0a41.jpg begin 644 image0a41.jpg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end